Citadel Advisors
TRIB

Citadel Advisors’s Trinity Biotech TRIB Stock Holding History

Citadel Advisors’s Portfolio TRIB Stock Details TRIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-39,384
Closed -$38.7K – 14089
2025
Q3 		$41K Buy
+39,384
New +$41.4K ﹤0.01% 12284
2025
Q2 		– Sell
-41,539
Closed -$27.8K – 15125
2025
Q1 		$23.7K Buy
+41,539
New +$32.8K ﹤0.01% 13022
2024
Q4 		– Sell
-14,151
Closed -$15.6K – 15403
2024
Q3 		$15.6K Buy
14,151
+3
+0% +$7 ﹤0.01% 12964
2024
Q2 		$29.3K Buy
+14,148
New +$27.5K ﹤0.01% 12300
2024
Q1 		– Sell
-6,503
Closed -$13.9K – 15446
2023
Q4 		$13.9K Buy
+6,503
New +$15.5K ﹤0.01% 12903
2023
Q3 		– Sell
-7,524
Closed -$36.3K – 15121
2023
Q2 		$36.3K Buy
7,524
+3,070
+69% +$14.9K ﹤0.01% 12151
2023
Q1 		$20.9K Buy
+4,454
New +$23K ﹤0.01% 13039
2022
Q1 		– Sell
-3,777
Closed -$21.8K – 14589
2021
Q4 		$27K Buy
3,777
+248
+7% +$2.34K ﹤0.01% 13511
2021
Q3 		$38K Sell
3,529
-448
-11% -$5.25K ﹤0.01% 13490
2021
Q2 		$58K Buy
3,977
+1,067
+37% +$17.8K ﹤0.01% 13273
2021
Q1 		$54K Buy
+2,910
New +$70K ﹤0.01% 12872
2020
Q4 		– Sell
-10,456
Closed -$173K – 11531
2020
Q3 		$105K Buy
10,456
+8,435
+417% +$97.6K ﹤0.01% 9247
2020
Q2 		$22K Buy
+2,021
New +$15.4K ﹤0.01% 9535
2017
Q1 		– Sell
-2,860
Closed -$99K – 8053
2016
Q4 		$99K Buy
+2,860
New +$98.5K ﹤0.01% 6682
2016
Q2 		– Sell
-2,629
Closed -$153K – 7415
2016
Q1 		$153K Buy
+2,629
New +$140K ﹤0.01% 5817
2015
Q2 		– Sell
-9,267
Closed -$892K – 9104
2015
Q1 		$892K Sell
9,267
-130
-1% -$12K ﹤0.01% 4074
2014
Q4 		$823K Buy
9,397
+1,958
+26% +$169K ﹤0.01% 4009
2014
Q3 		$680K Buy
7,439
+1,541
+26% +$167K ﹤0.01% 4206
2014
Q2 		$679K Buy
5,898
+2,304
+64% +$273K ﹤0.01% 3980
2014
Q1 		$436K Buy
3,594
+1,745
+94% +$229K ﹤0.01% 4543
2013
Q4 		$233K Buy
+1,849
New +$222K ﹤0.01% 4866

Other funds holding TRIB

HAIM
Hunter Associates Investment Management Pittsburgh, Pennsylvania $756M AUM 19.99% 1-Year Est. Return
YAG
Yorkville Advisors Global Mountainside, New Jersey $155M AUM 58.46% 1-Year Est. Return
WN
Williams & Novak Westlake Village, California $151M AUM 27.43% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
MAWA
Moss Adams Wealth Advisors Seattle, Washington $1.37B AUM 19.97% 1-Year Est. Return
IWA
Inspirion Wealth Advisors Libertyville, Illinois $874M AUM 16.23% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
BCM
Becker Capital Management Portland, Oregon $3.4B AUM 24.68% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Citadel Advisors's TRIB Position: Q4 2025 in Review

Citadel Advisors sold out of Trinity Biotech (TRIB) in Q4 2025, closing a stake of 39,384 shares — an estimated $38.7K sold.

Citadel Advisors first reported a position in TRIB in Q4 2013 and held it in 21 quarters. The position peaked at $892K in Q1 2015. 27 funds tracked by Wall St. Rank hold TRIB as of Q4 2025.

  • Citadel Advisors reported no remaining Trinity Biotech position as of Q4 2025 after selling out during the quarter.
  • Citadel Advisors sold 39,384 Trinity Biotech shares in Q4 2025, an estimated $38.7K.
  • Citadel Advisors first reported a position in Trinity Biotech in Q4 2013 and held it in 21 quarters.
  • Citadel Advisors's Trinity Biotech position peaked at $892K in Q1 2015.
  • 27 funds tracked by Wall St. Rank held Trinity Biotech as of Q4 2025.

Based on Citadel Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.